Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.
2.

Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.

van Hal SJ, Gilroy NM, Morrissey CO, Worth LJ, Szer J, Tam CS, Chen SC, Thursky KA, Slavin MA.

Intern Med J. 2014 Dec;44(12b):1277-82. doi: 10.1111/imj.12594. Review.

PMID:
25482740
3.

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.

Akan H, Antia VP, Kouba M, Sinkó J, Tănase AD, Vrhovac R, Herbrecht R.

J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii5-16. doi: 10.1093/jac/dkt389.

PMID:
24155144
4.

Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?

Rogers TR, Slavin MA, Donnelly JP.

Br J Haematol. 2011 Jun;153(6):681-97. doi: 10.1111/j.1365-2141.2011.08650.x. Epub 2011 Apr 20. Review.

PMID:
21504422
5.

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.

Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Styczynski J, Warris A, Lehrnbecher T; Fourth European Conference on Infections in Leukaemia; Infectious Diseases Working Party of the European Group for Blood Marrow Transplantation (EBMT-IDWP); Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (EORTC-IDG); International Immunocompromised Host Society (ICHS); European Leukaemia Net (ELN).

Lancet Oncol. 2014 Jul;15(8):e327-40. doi: 10.1016/S1470-2045(14)70017-8. Review.

PMID:
24988936
6.

Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.

Yunus S, Pieper S, Kolve H, Goletz G, Jürgens H, Groll AH.

J Antimicrob Chemother. 2014 Mar;69(3):815-20. doi: 10.1093/jac/dkt438. Epub 2013 Nov 5.

PMID:
24198097
7.

Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.

McCoy D, Depestel DD, Carver PL.

Pharmacotherapy. 2009 Nov;29(11):1306-25. doi: 10.1592/phco.29.11.1306. Review.

PMID:
19857148
8.

Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.

Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, Wu D, Ren H, Wang C, Shen Z, Ji Y, Huang X.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1117-26. doi: 10.1016/j.bbmt.2015.03.018. Epub 2015 Mar 31.

9.

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

Tacke D, Buchheidt D, Karthaus M, Krause SW, Maschmeyer G, Neumann S, Ostermann H, Penack O, Rieger C, Ruhnke M, Sandherr M, Schweer KE, Ullmann AJ, Cornely OA.

Ann Hematol. 2014 Sep;93(9):1449-56. doi: 10.1007/s00277-014-2108-y. Epub 2014 Jun 21. Review.

PMID:
24951122
10.

[Prevention of fungal infections in children and adolescents with cancer].

Groll AH, Ritter J, Müller FM.

Klin Padiatr. 2001 Sep;213 Suppl 1:A50-68. Review. German.

PMID:
11577364
11.

Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.

Tzadok R, Shapira MY, Moses AE, Or R, Block C, Strahilevitz J.

Mycoses. 2015 Dec;58(12):694-8. doi: 10.1111/myc.12416. Epub 2015 Oct 2.

PMID:
26429354
12.

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.

Wang CH, Kan LP, Lin HA, Chang FY, Wang NC, Lin TY, Chao TY, Kao WY, Ho CL, Chen YC, Dai MS, Chang PY, Wu YY, Lin JC.

J Microbiol Immunol Infect. 2016 Aug;49(4):531-8. doi: 10.1016/j.jmii.2014.07.009. Epub 2014 Oct 13.

13.

Antifungal prophylaxis: why, what and how?

Lyon S.

Future Microbiol. 2016;11(1):11-5. doi: 10.2217/fmb.15.129. Epub 2015 Dec 17.

14.

Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.

Corzo-León DE, Satlin MJ, Soave R, Shore TB, Schuetz AN, Jacobs SE, Walsh TJ.

Mycoses. 2015 Jun;58(6):325-36. doi: 10.1111/myc.12318. Epub 2015 Mar 24.

PMID:
25808822
15.

Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence.

Pechlivanoglou P, De Vries R, Daenen SM, Postma MJ.

Pharmacoeconomics. 2011 Sep;29(9):737-51. doi: 10.2165/11588370-000000000-00000. Review.

PMID:
21657801
16.

Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.

Blyth CC, Gilroy NM, Guy SD, Chambers ST, Cheong EY, Gottlieb T, McGuinness SL, Thursky KA.

Intern Med J. 2014 Dec;44(12b):1333-49. doi: 10.1111/imj.12598. Review.

PMID:
25482744
17.

Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.

Döring M, Cabanillas Stanchi KM, Queudeville M, Feucht J, Blaeschke F, Schlegel P, Feuchtinger T, Lang P, Müller I, Handgretinger R, Heinz WJ.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1281-1292. doi: 10.1007/s00432-017-2369-7. Epub 2017 Mar 3.

PMID:
28258343
18.

Recent advances in antifungal prevention and treatment.

Groll AH, Tragiannidis A.

Semin Hematol. 2009 Jul;46(3):212-29. doi: 10.1053/j.seminhematol.2009.03.003. Review.

PMID:
19549575
19.

Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.

Science M, Robinson PD, MacDonald T, Rassekh SR, Dupuis LL, Sung L.

Pediatr Blood Cancer. 2014 Mar;61(3):393-400. doi: 10.1002/pbc.24847. Epub 2013 Nov 26.

PMID:
24424789
20.

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.

Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M.

Cochrane Database Syst Rev. 2014 Apr 20;(4):CD010189. doi: 10.1002/14651858.CD010189.pub2. Review.

PMID:
24748537

Supplemental Content

Support Center